Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition

Item Type:	Article
Title:	Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition
Creators Name:	Allen, N.E. and Key, T.J. and Appleby, P.N. and Travis, R.C. and Roddam, A.W. and Rinaldi, S. and Egevad, L. and Rohrmann, S. and Linseisen, J. and Pischon, T. and Boeing, H. and Johnsen, N.F. and Tjonneland, A. and Gronbaek, H. and Overvad, K. and Kiemeney, L. and Bueno-de-Mesquita, H.B. and Bingham, S. and Khaw, K.T. and Tumino, R. and Berrino, F. and Mattiello, A. and Sacerdote, C. and Palli, D. and Quiros, J.R. and Ardanaz, E. and Navarro, C. and Larranaga, N. and Gonzalez, C. and Sanchez, M.J. and Trichopoulou, A. and Travezea, C. and Trichopoulos, D. and Jenab, M. and Ferrari, P. and Riboli, E. and Kaaks, R.
Abstract:	Some studies suggest that elevated serum insulin-like growth factor (IGF)-I concentrations are associated with an increased risk of prostate cancer and, in particular, with an increased risk of advanced-stage prostate cancer.
Keywords:	Prospective, Prostate Cancer, Serum, IGF-I, IGFBP-3, EPIC
Source:	Cancer Epidemiology Biomarkers & Prevention
ISSN:	1055-9965
Publisher:	American Association for Cancer Research
Volume:	16
Number:	6
Page Range:	1121-1127
Date:	June 2007
Official Publication:	https://doi.org/10.1158/1055-9965.EPI-06-1062
PubMed:	View item in PubMed

Repository Staff Only: item control page